Global momentum builds for avian influenza vaccination as control strategy across multiple poultry sectors
International organizations including the FAO and WOAH released a comprehensive framework in 2024-2033 positioning vaccination as essential for managing highly pathogenic avian influenza, with significant progress achieved in 2025. Multiple countries including the Philippines, South Africa, Hungary, Italy, and the Netherlands have approved or implemented HPAI vaccination programs for various poultry species, with field trials demonstrating reduced infection rates. The United States egg and turkey industries released targeted vaccination frameworks, while emerging H5N1 outbreaks in South America since 2022 have underscored the need for coordinated vaccination strategies globally.
The 2024-2033 global framework from FAO and WOAH represents a coordinated shift in how the international poultry industry addresses highly pathogenic avian influenza. Rather than relying exclusively on culling infected flocks and biosecurity measures, major producing nations have begun licensing and deploying vaccines across multiple bird species. Field results from multiple countries—including three years of duck vaccination in France and laying hen trials in the Netherlands—have shown measurable reductions in infection rates among vaccinated populations, providing evidence supporting broader adoption.
Vaccine technology varies significantly in approach and application method. Most authorized vaccines (95.5% of the market) are inactivated formulations requiring periodic boosters, while a smaller segment uses vector-based platforms that trigger stronger immune responses. Administration occurs either at hatcheries through in-ovo or subcutaneous injection, or at farm level in adult birds, with serological testing used to confirm vaccine effectiveness.
This shift toward vaccination could reshape how major poultry producers manage disease risk and maintain production continuity during outbreaks. Countries implementing coordinated vaccination strategies may experience lower economic losses from culling operations and supply disruptions, potentially stabilizing global egg and poultry meat availability. However, success depends on consistent international coordination, access to approved vaccines across regions, and farmer compliance with monitoring protocols—challenges that may affect smaller or less-resourced producers differently than large operations.